DNA repair genes XPD and XRCC1 polymorphisms and risk of end-stage renal disease in Egyptian population

References

• Gutiérrez-Amavizca BE, Orozco-Castellanos R, Ortíz-Orozco R, et al. Contribution of GSTM1, GSTT1, and MTHFR polymorphisms to end-stage renal disease of unknown etiology in Mexicans. Indian J Nephrol. 2013;23(6):438–443
   PubMedGoogle Scholar
• Schupp N, Stopper H, Rutkowski P, et al. Effect of different hemodialysis regimens on genomic damage in end-stage renal failure. Semin Nephrol. 2006;26:28–32
   PubMed Web of Science ®Google Scholar
• Guven M, Guven GS, Oz E, et al. DNA repair gene XRCC1 and XPD polymorphisms and their association with coronary artery disease risks and micronucleus frequency. Heart Vessels. 2007;22:355–360
   PubMed Web of Science ®Google Scholar
• Maisonneuve P, Agodoa L, Gellert R, et al. Cancer in patients on dialysis for end-stage renal disease: An international collaborative study. Lancet. 1999;354:93–99
   PubMed Web of Science ®Google Scholar
• Tepel M, Echelmeyer M, Orie NN, Zidek W. Increased intracellular reactive oxygen species in patients with end-stage renal failure: Effect of hemodialysis. Kidney Int. 2000;58:867–872
   PubMed Web of Science ®Google Scholar
• Floccari F, Aloisi C, Crascì E. Oxidative stress and uremia. Med Res Rev. 2005;25:473–486
   PubMedGoogle Scholar
• Locatelli F, Canaud B, Eckardt KU, Stenvinkel P, Wanner C, Zoccali C. Oxidative stress in end-stage renal disease: An emerging threat to patient outcome. Nephrol Dial Transplant. 2003;18:1272–1280
   PubMed Web of Science ®Google Scholar
• Cadet J, Douki T, Ravanat JL. Measurement of oxidatively generated base damage in cellular DNA. Mutat Res. 2011;711:3–12
   PubMed Web of Science ®Google Scholar
• Stern MC, Siegmund KD, Conti DV, Corral R, Haile RW. XRCC1, XRCC3, and XPD polymorphisms as modifiers of the effect of smoking and alcohol on colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev. 2006;15:2384–2390
   PubMedGoogle Scholar
• Shen MR, Jones IM, Mohrenweiser H. Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res. 1998;58:604–608
   PubMed Web of Science ®Google Scholar
• Lunn RM, Langlois RG, Hsieh LL, Thompson CL, Bell DA. XRCC1 polymorphisms: Effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency. Cancer Res. 1999;59:2557–2561
   PubMed Web of Science ®Google Scholar
• Benhamou S, Sarasin A. ERCC2/XPD gene polymorphisms and cancer risk. Mutagenesis 2002;17:463–469
   PubMed Web of Science ®Google Scholar
• Catana A, Popp RA, Pop M, Porojan MD, Petrisor FM and Pop IV. Genetic polymorphism of DNA repair gene ERCC2/XPD (Arg 156 Arg) (A22541C) and lung cancer risk in Northern Romania. Rev Romănă Med Lab. 2012;20(2):157–161
   Google Scholar
• Procopciuc LM, Osian G. Interaction between lifestyle factors and the XRCC1, XPD, and XRCC3 genetic variations modulates the risk for sporadic colorectal cancer. Rev Romănă Med Lab. 2014;22(1):129–141
   Google Scholar
• Yeh CC, Sung FC, Tang R, Chang-Chieh CR, Hsieh LL. Polymorphisms of the XRCC1, XRCC3, and XPD genes, and colorectal cancer risk: A case-control study in Taiwan. BMC Cancer. 2005;5:12
   PubMed Web of Science ®Google Scholar
• Güven M, Unal M, Batar B, et al. Polymorphisms of DNA repair genes XRCC1 and XPD and risk of primary open angle glaucoma (POAG). Mol Vis. 2007;13:12–17
   PubMed Web of Science ®Google Scholar
• Unal M, Güven M, Batar B, Ozaydin A, Sarici A, Devranoğlu K. Polymorphisms of DNA repair genes XPD and XRCC1 and risk of cataract development. Exp Eye Res. 2007;85:328–334
   PubMed Web of Science ®Google Scholar
• Sorour A, Ayad MW, Kassem H. The genotype distribution of the XRCC1, XRCC3, and XPD DNA repair genes and their role for the development of acute myeloblastic leukemia. Genet Test Mol Biomarkers. 2013;17(3):195–201
   PubMedGoogle Scholar
• Özcan A, Pehlivan M, Tomatir AG, et al. Polymorphisms of the DNA repair gene XPD (751) and XRCC1 (399) correlates with risk of hematological malignancies in Turkish population. Afr J Biotechnol. 2011;10(44):8860–8870
   Google Scholar
• Shi JY, Ren ZH, Jiao B, et al. Genetic variations of DNA repair genes and their prognostic significance in patients with acute myeloid leukemia. Int J Cancer. 2011;128(1):233–238
   PubMed Web of Science ®Google Scholar
• Caldecott KW. XRCC1 and DNA strand break repair. DNA Repair (Amst). 2003;2:955–969
   PubMed Web of Science ®Google Scholar
• El-Din MS, Raslan H, Abdel-Hamid S, Makhlouf M. Detection of XRCC1 gene polymorphisms in Egyptian patients with acute myeloid leukemia. Comp Clin Pathol. 2012;21(5):505–513
   Google Scholar
• Kuptsova N, Kopecky KJ, Godwin J, et al. Polymorphisms in DNA repair genes and therapeutic outcomes of AML patients from SWOG clinical trials. Blood. 2007;109(9):3936–3944
   PubMed Web of Science ®Google Scholar
• Joseph T, Kusumakumary P, Chacko P, Abraham A, Pillai MR. DNA repair gene XRCC1 polymorphisms in childhood acute lymphoblastic leukemia. Cancer Lett. 2005;217(1):17–24
   PubMedGoogle Scholar
• Meza-Espinoza JP, Peralta-Leal V, Gutierrez-Angulo M, et al. XRCC1 polymorphisms and haplotypes in Mexican patients with acute lymphoblastic leukemia. Genet Mol Res. 2009;8(4):1451–1458
   PubMedGoogle Scholar
• Ganster C, Neesen J, Zehetmayer S, et al. DNA repair polymorphisms associated with cytogenetic subgroups in B cell chronic lymphocytic leukemia. Genes Chromosomes Cancer. 2009;48:760–767
   PubMed Web of Science ®Google Scholar
• Liu J, Song B, Wang Z, et al. DNA repair gene XRCC1 polymorphisms and non-Hodgkin lymphoma risk in a Chinese population. Cancer Genetics Cytogenet. 2009;191(2):67–72
   PubMedGoogle Scholar
• Smedby KE, Lindgren CM, Hjalgrim H, et al. Variation in DNA repair genes ERCC2, XRCC1, and XRCC3 and risk of follicular lymphoma. Cancer Epidemiol Biomarkers Prev. 2006;15(2):258–265
   PubMedGoogle Scholar
• Bsnescu C, Trifa AP, Demian S, et al. Polymorphism of XRCC1, XRCC3, and XPD genes and risk of chronic myeloid leukemia. BioMed Res Int. 2014. [Epub ahead of print]
   Google Scholar
• Ladiges W, Wiley J, MacAuley A. Polymorphisms in the DNA repair gene XRCC1 and age-related disease. Mech Ageing Dev. 2003;124:27–32
   PubMed Web of Science ®Google Scholar
• Yuan T, Deng S, Liu H, Liu M, Chen P. Relationship between XRCC1 and XPD polymorphisms and the risk of the development of hepatocellular carcinoma: A case-control study. Exp Ther Med. 2012;4(2):285–290
   PubMedGoogle Scholar
• Guo LY, Jin XP, Niu W, Li XF, Liu BH, Wang YL. Association of XPD and XRCC1 genetic polymorphisms with hepatocellular carcinoma risk. Asian Pac J Cancer Prev. 2012;13(9):4423–4426
   PubMedGoogle Scholar
• Batar B, Güven M, Bariş S, Celkan T, Yildiz I. DNA repair gene XPD and XRCC1 polymorphisms and the risk of childhood acute lymphoblastic leukemia. Leuk Res. 2009;33(6):759–763
   PubMed Web of Science ®Google Scholar
• Benhamou S, Sarasin A. Variability in nucleotide excision repair and cancer risk: A review. Mutat Res. 2000;462:149–158
   PubMed Web of Science ®Google Scholar
• Trabulus S, Guven GS, Altiparmak MR, et al. DNA repair XRCC1 Arg399Gln polymorphism is associated with the risk of development of end-stage renal disease. Mol Biol Rep. 2012;39(6):6995–7001
   PubMedGoogle Scholar
• Coin F, Marinoni JC, Rodolfo C, Fribourg S, Pedrini AM, Egly JM. Mutations in the XPD helicase gene result in XP and TTD phenotypes, preventing interaction between XPD and the p44 subunit of TFIIH. Nat Genet. 1998;20:184–188
   PubMed Web of Science ®Google Scholar
• Nazarkina ZK, Khodyreva SN, Marsin S, Lavrik OI, Radicella JP. XRCC1 interactions with base excision repair DNA intermediates. DNA Repair (Amst). 2007;6:254–264
   PubMed Web of Science ®Google Scholar
• Battershill JM, Burnett K, Bull S. Factors affecting the incidence of genotoxicity biomarkers in peripheral blood lymphocytes: Impact on design of biomonitoring studies. Mutagenesis. 2008;23:423–437
   PubMed Web of Science ®Google Scholar
• Chiang CC, Tsai YY, Bau DT, et al. Pterygium and genetic polymorphisms of the DNA repair enzymes XRCC1, XPA, and XPD. Mol Vis. 2010;16:698–704
   PubMedGoogle Scholar
• Padma G, Mamata M, Reddy KR, Padma T. Polymorphisms in two DNA repair genes (XPD and XRCC1)—Association with age related cataracts. Mol Vis. 2011;17:127–133
   PubMed Web of Science ®Google Scholar
• Warchoł T, Mostowska A, Lianeri M, Lącki JK, Jagodziński PP. XRCC1 Arg399Gln gene polymorphism and the risk of systemic lupus erythematosus in the polish population. DNA Cell Biol. 2012;31:50–56
   PubMedGoogle Scholar
• Silva SN, Moita R, Azevedo AP, et al. Menopausal age and XRCC1 gene polymorphisms: Role in breast cancer risk. Cancer Detect Prev. 2007;31:303–309
   PubMedGoogle Scholar
• Butkiewicz D, Rusin M, Sikora B, Lach A, Chorązy M. An association between DNA repair gene polymorphisms and survival in patients with resected non-small cell lung cancer. Mol Biol Rep. 2011;38:5231–5241
   PubMedGoogle Scholar
• Berhane N, Sobti RC, Mahdi SA. DNA repair genes polymorphism (XPG and XRCC1) and association of prostate cancer in a north Indian population. Mol Biol Rep. 2012;39(3):2471–2479
   PubMedGoogle Scholar
• Sturgis EM, Castilli EJ, Li L, et al. Polymorphisms of DNA repair gene XRCC1 in squamous cell carcinoma of the head and the neck. Carcinogenesis. 1999;20:2125–2129
   PubMed Web of Science ®Google Scholar
• Duarte MC, Colombo J, Rossit AR, et al. Polymorphisms of DNA repair genes XRCC1 and XRCC3, interaction with environmental exposure and risk of chronic gastritis and gastric cancer. World J Gastroenterol. 2005;11:6593–6600
   PubMed Web of Science ®Google Scholar
• Abdel-Rahman S, Soliman AS, Bondy ML, et al. Inheritance of the 194Trp and the 399Gln variant alleles of the DNA repair gene XRCC1 are associated with increased risk of early-onset colorectal carcinoma in Egypt. Cancer Lett. 2000;159:79–86
   PubMed Web of Science ®Google Scholar
• Tumer TB, Yilmaz D, Tanrikut C, Sahin G, Ulusoy G, Arinc E. DNA repair XRCC1 Arg399Gln polymorphism alone, and in combination with CYP2E1 polymorphisms significantly contribute to the risk of development of childhood acute lymphoblastic leukemia. Leuk Res. 2010;34:1275–1281
   PubMed Web of Science ®Google Scholar
• Hirata H, Hinoda Y, Matsuyama H, et al. Polymorphisms of DNA repair genes are associated with renal cell carcinoma. Biochem Biophys Res Commun. 2006;342:1058–1062
   PubMedGoogle Scholar
• Görgün E, Güven M, Unal M, et al. Polymorphisms of the DNA repair genes XPD and XRCC1 and the risk of age-related macular degeneration. Invest Ophthalmol Vis Sci. 2010;51:4732–4737
   PubMedGoogle Scholar
• Gao W, Romkes M, Zhong S, et al. Genetic polymorphisms in the DNA repair genes XPD and XRCC1, p53 gene mutations and bladder cancer risk. Oncol Rep. 2010;24:257–262
   PubMed Web of Science ®Google Scholar
• Huang CG, Iv GD, Liu T, Liu Q, Feng JG, Lu XM. Polymorphisms of COMT and XPD and risk of esophageal squamous cell carcinoma in a population of Yili Prefecture, in Xinjiang, China. Biomarkers. 2011;16:37–41
   PubMed Web of Science ®Google Scholar